Voiding Dysfunction Among Older Adults With Non-Muscle Invasive Bladder Cancer: Incidence and Predictors of Treatment for Overactive Bladder

The authors aimed to evaluate the incidence and predictors of treatment for overactive bladder (OAB) among older adults diagnosed with non-muscle invasive bladder cancer (NMIBC). They found that 7% of patients initiated OAB treatment within the first year post-diagnosis, increasing to 15% by five years, with factors such as female gender, congestive heart failure, and T1 tumor stage being significant predictors of treatment. This study highlights the substantial urinary morbidity associated with NMIBC and suggests that certain clinicopathologic features may guide clinical counseling regarding OAB management.